1. Recombinant human thrombopoietin augments mobilization of peripheral blood progenitor cells for autologous transplantation 
Charles Linker, Paolo Anderlini, Roger Herzig, Neal Christiansen, George Somlo, William Bensinger, Joseph Fay, Joseph P Lynch, Lawrence T Goodnough, Mark Ashby, Mark C Benyunes, Dennie V Jones, Timothy A Yang, Langdon L Miller, Charles Weaver 
Biology of Blood and Marrow Transplantation 
Volume 9, Issue 6, Pages (June 2003)
DOI: /S (03)

2. Figure 1
Study schema of the treatment schedule of study drug (rhTPO or placebo) and growth factors (granulocyte colony-stimulating factor [G-CSF] or granulocyte-macrophage colony-stimulating factor [GM-CSF]) during stem cell mobilization and transplantation. PBPC, peripheral blood progenitor cell.
Biology of Blood and Marrow Transplantation 2003 9, DOI: ( /S (03) )

3. Figure 2
Proportion of patients achieving the target cell graft (5.0 × 106 CD34+ cells/kg) by treatment group and leukapheresis day.
Biology of Blood and Marrow Transplantation 2003 9, DOI: ( /S (03) )